Zega Financial LLC Sells 130 Shares of The Procter & Gamble Company (NYSE:PG)

Zega Financial LLC cut its position in The Procter & Gamble Company (NYSE:PG) by 2.6% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 4,883 shares of the company’s stock after selling 130 shares during the quarter. Zega Financial LLC’s holdings in Procter & Gamble were worth $805,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently bought and sold shares of the company. HighPoint Advisor Group LLC bought a new stake in shares of Procter & Gamble in the fourth quarter valued at approximately $17,696,000. Bayesian Capital Management LP raised its stake in Procter & Gamble by 43.0% during the 4th quarter. Bayesian Capital Management LP now owns 52,840 shares of the company’s stock valued at $7,743,000 after purchasing an additional 15,900 shares during the last quarter. Steele Capital Management Inc. bought a new stake in Procter & Gamble in the 1st quarter valued at $204,000. Gilbert & Cook Inc. grew its position in Procter & Gamble by 7.7% in the 4th quarter. Gilbert & Cook Inc. now owns 17,215 shares of the company’s stock worth $2,523,000 after purchasing an additional 1,237 shares during the last quarter. Finally, Mosley Wealth Management bought a new position in shares of Procter & Gamble during the 4th quarter worth about $537,000. Institutional investors own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total value of $16,320,000.00. Following the completion of the transaction, the chief executive officer now owns 13,721 shares in the company, valued at approximately $2,332,570. The disclosure for this sale can be found here. Insiders sold a total of 375,553 shares of company stock valued at $63,829,141 over the last quarter. Corporate insiders own 0.17% of the company’s stock.

Analysts Set New Price Targets

PG has been the subject of several research reports. BNP Paribas started coverage on shares of Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 target price for the company. Barclays reduced their price objective on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Jefferies Financial Group cut Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Citigroup raised their target price on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Finally, DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a report on Thursday, August 29th. Seven research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $175.79.

Procter & Gamble Trading Down 0.7 %

Shares of PG opened at $175.93 on Wednesday. The stock has a fifty day moving average price of $169.80 and a two-hundred day moving average price of $165.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The company has a market cap of $415.22 billion, a price-to-earnings ratio of 28.75, a PEG ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $177.94.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. During the same quarter in the prior year, the company earned $1.37 EPS. The firm’s quarterly revenue was down .1% on a year-over-year basis. Analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $4.03 annualized dividend and a dividend yield of 2.29%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.85%.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.